Utilization of palliative care consultations in pediatric oncology phase I clinical trials | Zendy

Cuviello Andrea | Zendy; Boss Renee | Zendy; Shah Nirali | Zendy; Battles Haven | Zendy; Beri Andrea | Zendy; Wiener Lori | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Utilization of palliative care consultations in pediatric oncology phase I clinical trials

Author(s) -

Cuviello Andrea,

Boss Renee,

Shah Nirali,

Battles Haven,

Beri Andrea,

Wiener Lori

Publication year - 2019

Publication title -

pediatric blood and cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.116

H-Index - 105

eISSN - 1545-5017

pISSN - 1545-5009

DOI - 10.1002/pbc.27771

Subject(s) - medicine , palliative care , intensive care medicine , clinical trial , pediatric oncology , quality of life (healthcare) , refractory (planetary science) , disease , retrospective cohort study , medline , cancer , nursing , physics , astrobiology , political science , law

Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research